Schonfeld Strategic Advisors »

Nektar Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $580k 8.1k 71.95
2025-06-30 $2.6M 102k 25.84

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Nektar Therapeutics

BVF
Two Seas Capital
Vanguard Capital Management
Susquehanna International
Vanguard Group
Two Sigma Investments
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Prosight Management
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics